- Home
- APLM vs RAYA Comparison
APLM vs RAYA Comparison
Compare APLM & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- RAYA
- Stock Information
- Founded
- APLM 2016
- RAYA 2019
- Country
- APLM United States
- RAYA China
- Employees
- APLM N/A
- RAYA N/A
- Industry
- APLM Blank Checks
- RAYA Metal Fabrications
- Sector
- APLM Finance
- RAYA Consumer Discretionary
- Exchange
- APLM Nasdaq
- RAYA Nasdaq
- Market Cap
- APLM 6.1M
- RAYA 6.1M
- IPO Year
- APLM N/A
- RAYA 2022
- Fundamental
- Price
- APLM $5.48
- RAYA $0.05
- Analyst Decision
- APLM
- RAYA
- Analyst Count
- APLM 0
- RAYA 0
- Target Price
- APLM N/A
- RAYA N/A
- AVG Volume (30 Days)
- APLM 33.5K
- RAYA 60.8M
- Earning Date
- APLM 09-16-2025
- RAYA 01-01-0001
- Dividend Yield
- APLM N/A
- RAYA N/A
- EPS Growth
- APLM N/A
- RAYA N/A
- EPS
- APLM N/A
- RAYA N/A
- Revenue
- APLM $198,000.00
- RAYA $30,300,360.00
- Revenue This Year
- APLM $415.15
- RAYA $20.95
- Revenue Next Year
- APLM N/A
- RAYA N/A
- P/E Ratio
- APLM N/A
- RAYA N/A
- Revenue Growth
- APLM N/A
- RAYA 49.10
- 52 Week Low
- APLM $3.66
- RAYA $0.04
- 52 Week High
- APLM $35.98
- RAYA $3.35
- Technical
- Relative Strength Index (RSI)
- APLM 49.97
- RAYA 27.62
- Support Level
- APLM $3.66
- RAYA $0.05
- Resistance Level
- APLM $6.37
- RAYA $0.07
- Average True Range (ATR)
- APLM 0.54
- RAYA 0.01
- MACD
- APLM -0.10
- RAYA 0.06
- Stochastic Oscillator
- APLM 67.17
- RAYA 30.80
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.